Hepatitis C virus infection in dialysis: A continuing problem

Artificial Organs

Volumn 23, Issue 1, 1999, Pages 51-60

  Pereira, Brian J G ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Dialysis infection; Hepatitis C virus; Liver disease

Indexed keywords

HEMODIALYZERS; VIRUSES;

BLOOD PRODUCTS; CLINICAL COURSE; DIALYSIS INFECTION; HAEMODIALYSIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS VIRUS; LIVER DISEASE; LIVER FUNCTIONS; VIRUS INFECTION;

DIALYSIS;

ARTIFICIAL KIDNEY; BLOOD TRANSFUSION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSIS MEMBRANE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER FUNCTION; MACHINE; NEEDLESTICK INJURY; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIRUS TRANSMISSION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; NON-A, NON-B HEPATITIS VIRUS;

EID: 0032946750     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.1999.06274.x     Document Type: Review

References (87)

1. Choo Q, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:358-62.
2. Kuo G, Choo QL, Alter HJ, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Teghmeier GE, Bonino F, Colombo M, Lee W-S, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
3. Weiner AJ, Kuo G, Bradley DW, Bonino F, Saracco G, Lee C, Rosenblatt J, Choo QL, Houghton M. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 1990; 335:1-3.
4. Okamoto H, Okada S, Sugiyama T, Tanaka T, Sugai Y, Akahaney Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990;60:215-22.
5. Donahue JG, Muñoz A, Ness PM, Brown DE, Yawn DH, McAllister HA, Reitz BA, Nelson KE. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-73.
6. Pereira BJG, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997;51:981-99.
7. Blackmore TK, Maddocks P, Stace NH, Hatfield P. Prevalence of antibodies to hepatitis C virus in patients receiving renal replacement therapy, and in the staff caring for them. Aust NZ J Med 1992;22:353-7.
8. Niu MT, Coleman PJ, Alter MJ. Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members. Am J Kidney Dis 1993;22:568-73.
9. Modelli MU, Cristina G, Pazza V, Cerino A, Villa G, Salvadeo A. High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay. Nephron 1992;61:350-1.
10. Sheu JC, Lee SH, Wang JT, Shih LN, Wang TH, Chen DS. Prevalence of anti-HCV and HCV viremia in hemodialysis patients in Taiwan. J Med Virol 1992;37:108-12.
11. Natov SN, Pereira BJG. Hepatitis C infection in patients on dialysis. Semin Dial 1994;7:360-8.
12. Tokars J, Alter MJ, Favero MS, Moyer LA, Miller E, Bland L. National surveillance of hemodialysis associated diseases in the United States, 1992. ASAIO J 1994;40:1020-31.
13. Loureiro A, Pinto dos Santos J, Schmid CS, Pereira BJG. Trends in incidence of hepatitis C (HCV) infection in hemodialysis (HD) units (Abstract). J Am Soc Nephrol 1995;6:547.
14. Huraib S, al-Rashed R, Aldrees A, Aljefry M, Arif M, al-Faleh FA. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: A need for new dialysis strategies. Nephrol Dial Transplant 1995;10:470-4.
15. Geerlings W, Tufveson G, Ehrich JHH, Jones EH, Landais P, Loriat C, Mallick NP, Margreiter R, Raine EE, Salmela K, Selwood NH, Valderrabano F. Report on the management of renal failure in Europe, XXIII. Nephrol Dial Transplant 1994;9:6-25.
16. Valderrábano F, Jones EHP, Mallick NP. Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant 1995;10(Suppl. 5):1-25.
17. Medici G, Depetri GC, Mileti M. Anti-hepatitis C virus positivity and clinical correlations in hemodialyzed patients. Nephron 1992;61:363-4.
18. Hardy NM, Sandroni S, Danielson S, Wilson WJ. Antibody to hepatitis C virus increases with time on dialysis. Clin Nephrol 1992;38:44-8.
19. Alter MJ, Favero MS, Maynard JE. Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States. J Infect Dis 1986;153:1149-51.
20. Oguchi H, Miyasaka M, Tokunaga S, Hora K, Ichikawa S, Ochi T, Yamada K, Nagasawa M, Kanno Y, Aizawa T, Watanabe H, Yoshizawa S, Sato K, Terashima M, Yoshie T, Oguchi S, Tanaka E, Kiyosawa K, Furuta S. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin Nephrol 1992;38:36-43.
21. Selgas R, Martinez-Zapico R, Bajo MA, Romero JR, Munoz J, Rinon C, Miranda B, Miguel JL. Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center. Perit Dial Int 1992;12:28-30.
22. Cendoroglo Neto M, Manzano SI, Canziani ME, Silva AE, Cirenza LF, Sesso RdC, Ajzen H, Draibe SA. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit. Artif Organs 1995;19:251-5.
23. Huang CC, Wu MS, Lin DY, Liaw YF. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1992;12:31-3.
24. Conway M, Catterall AP, Brown EA, Tibbs C, Gower PE, Curtis JR, Coleman JC, Murray-Lyon IM. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission. Nephrol Dial Transplant 1992;7:1226-9.
25. Chan TM, Lok ASF, Cheng IKP. Hepatitis C infection among dialysis patients: A comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991;6:944-7.
26. Gilli P, Moretti M, Soffritti S, Marchi N, Malacarne F, Bedani PL, De Paoli Vitali E, Fiocchi O, Menini C. Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients. Int J Artif Organs 1990;13:737-41.
27. Pascual J, Teruel JL, Mateos M, Liano F, Serrano P, Marcen R, Ortuno J. Nosocomial transmission of hepatitis C virus (HCV) infection in a hemodialysis (HD) unit during two years of prospective follow-up (Abstract). J Am Soc Nephrol 1992;3:386.
28. Barril G, Traver JA. Prevalence of hepatitis C virus in dialysis patients in Spain. Nephrol Dial Transplant 1995;10(Suppl. 6):78-80.
29. Bruguera M, Vidal L, Sanchez-Tapias JM, Costa J, Revert L, Rodes J. Incidence and features of liver disease in patients on chronic hemodialysis. J Clin Gastroenterol 1990;12:298-302.
30. Pinto dos Santos J, Loureiro A, Cendoroglo M, Pereira BJG. Impact of dialysis room and reuse strategies on the incidence of HCV infection in HD units. Nephrol Dial Transplant 1996;11:2017-22.
31. Jadoul M, Cornu C, Van Ypersele de Strihou C, the UCL Collaborative Group. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study. Kidney Int 1993;44:1322-6.
32. Corcoran GD, Brink NS, Millar C, Garson J, Waite J, Deaville R, Thompson F, Tedder R. Hepatitis C virus infection in hemodialysis patients: A clinical and virological study. J Infect Dis 1994;28:279-85.
33. Sampietro M, Badalamenti S, Salvadori S, Corbetta N, Graziani G, Como G, Fiorelli G, Ponticelli C. High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: Evidence for nosocomial transmission of HCV. Kidney Int 1995;47:911-7.
34. McIntyre PG, McCruden EA, Dow BC, Cameron SO, McMillan MA, Allison ME, Briggs JD. Hepatitis C virus infection in renal dialysis patients in Glasgow. Nephrol Dial Transplant 1994;9:291-5.
35. DuBois DB, Gretch D, dela Rosa C, Lee W, Fine J, Blagg CR, Corey L. Quantitation of hepatitis C viral RNA in sera of hemodialysis patients: Gender-related differences in viral load. Am J Kidney Dis 1994;24:795-801.
36. Jeffers LJ, Perez GO, de Medina MD, Ortiz-Interian CJ, Schiff ER, Reddy KR, Jimenez M, Bourgoignie JJ, Vaamonde CA, Duncan R, Houghton M, Choo OL, Kuo G. Hepatitis C infection in two urban hemodialysis units. Kidney Int 1990;38:320-2.
37. Alter M, Hadler SC, Judson FN, Mares A, Alexander J, Hu PY, Miller JK, Moyer LA, Fields HA, Bradley DW, Margolis HS. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990;264:2231-5.
38. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992;327:1899-905.
39. Schlipköter U, Roggendorf M, Cholmakow K, Weise A, Dienhardt. Transmission of hepatitis C virus (HCV) from a haemodialysis patient to a medical staff member. Scan J Infect Dis 1990;22:757-8.
40. Kiyosawa K, Sodeyama T, Tanaka E, Nakano Y, Furuta S, Nishioka K, Purcell RH, Alter HJ. Hepatitis C in hospital employees with needle stick injuries. Ann Intern Med 1991;115:367-9.
41. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato, Tsuda T, Miyakawa Y, Mayumi M. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-9.
42. Mitsui T, Iwano K, Masuko K, Yamazaki C, Okamoto H, Tsuda F, Tanaka T, Mishiro S. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 1992;16:1109-14.
43. Masuko K, Mitsui T, Iwano K, Yamazaki C, Aihara C, Baba K, Tkai E, Tsuda F, Nakamura T, Miyakawa Y, Mayumi M. Factors influencing post-exposure immunoprophylaxis of hepatitis B virus infection with hepatitis B immune globulin. High deoxyribonucleic acid polymerase activity in the inocula of unsuccessful cases. Gastroenterology 1985;88:151-5.
44. Bradley DW. Hepatitis non-A, non-B viruses become identified as hepatitis C and E viruses. Prog Med Virol 1990;37:101-35.
45. Yoshizawa H, Otoh Y, Iwakiri K, Tanaka A, Tachibana T. Non-A, non-B (type 1) hepatitis agent capable of inducing tubular structures in the hepatocyte cytoplasm of chimpanzees: Inactivation by formalin and heat. Gastroenterology 1982;82:502-6.
46. Shikata T, Karasawa T, Abe K, Uzawa T, Suzuki H, Oda T, Imai M, Mayumi M, Moritsugu Y. Hepatitis B e antigen and infectivity of hepatitis B virus. J Infect Dis 1977;136:571-6.
47. Ponzetto A, Hoyer BH, Popper H, Engle R, Purcell RH, Gerin JL. Titration of the infectivity of hepatitis D virus in chimpanzees. J Infect Dis 1987;155:122-8.
48. Alter MJ, Favero MS, Moyer LA, Bland LA. National surveillance of dialysis-associated diseases in the United States, 1989. ASAIO Trans 1991;37:97-109.
49. Okuda K, Hayashi H, Yokozeki K. Mode of nosocomial HCV infection among chronic hemodialysis patients and its prevention. Hepatology 1994;19:293.
50. Niu MT, Alter MJ, Kristensen C, Margolis HS. Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody for hepatitis C virus. Am J Kidney Dis 1992;19:345-52.
51. Garcia-Valdescasas J, Bernal MC, Cerezo S, Garcia F, Pereira BJG. Strategies to reduce the transmission of HCV infection in hemodialysis (HD) units (Abstract). J Am Soc Nephrol 1993;4:347.
52. Da Porto A, Adami A, Susanna F, Calzavara P, Poli P, Castelletto MR, Amici GP, Teodori T, Okolicsanyi L. Hepatitis C virus in dialysis units: A multicenter study. Nephron 1992;61:309-10.
53. Brugnano R, Francisci D, Quintaliani G, Gaburri M, Nori G, Verdura C, Giombini L, Buoncristiani U. Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: Evaluation of some risk factors. Nephron 1992;61:263-5.
54. Mitwalli A, Al-Mohaya S, Al Wakeel J, El Gamal H, Rotimi V, Al-Zeben A, Al-Aska A. Hepatitis C in chronic renal failure patients. Am J Nephrol 1992;12:288-91.
55. Vagelli G, Calabrese G, Guaschino R, Gonella M. Effect of HCV+ patients isolation on HCV infection incidence in a dialysis unit (Letter). Nephrol Dial Transplant 1992;7:1070.
56. Calabrese G, Vagelli G, Guaschino R, Gonella M. Transmission of anti-HCV within the households of hemodialysis patients. Lancet 1991;338:1466.
57. Yuasa T, Ishikawa G, Manabe S, Sekiguchi S, Takeuchi K, Miyamura T. The particle size of hepatitis C virus estimated by filtration through microporous regenerated cellulose fibre. J Gen Virol 1991;72:2021-4.
58. Hubmann R, Zazgornik J, Gabriel C, Garbeis B, Blauhut B. Hepatitis C virus - Does it penetrate the haemodialysis membrane? PCR analysis of haemodialysis ultrafiltrate and whole blood. Nephrol Dial Transplant 1995;10:541-2.
59. Caramelo C, Navas S, Alberola ML, Bermejillo T, Reyero A, Carreno V. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid. Nephron 1994;66:470-3.
60. Lombardi M, Cerrai T, Dattolo P, Pizzarelli F, Michelassi S, Maggiore Q, Zignego AL. Is the dialysis membrane a safe barrier against HCV infection? Nephrol Dial Transplant 1995;10:578-9.
61. Muller GY, Zabaleta ME, Arminio A, Colmenares CJ, Capriles FI, Bianco NE, Machado IV. Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int 1992;41:1055-8.
62. Lin DY, Lin HH, Huang CC, Liaw YF. High incidence of hepatitis C virus infection in hemodialysis patients in Taiwan. Am J Kidney Dis 1993;21:288-91.
63. Tokars J, Alter MJ, Favero MS, Moyer LA, Bland LE. National surveillance of hemodialysis associated diseases in the United States, 1990. ASAIO J 1993;39:71-80.
64. Cuypers H, Bresters D, Winkel I, Reesink H, Weiner A, Houghton M, Vander Poel C, Lelic P. Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus. J Clin Microbiol 1992;30:3220-4.
65. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, Purcell RH; Lack of protective immunity against reinfection with hepatitis C virus. Science 1992;258:135-40.
66. Pol S, Romeo R, Zins B, Driss F, Lebriki B, Carnot F, Berthelot, Bréchot C. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: Significance and therapeutic implications. Kidney Int 1993;44:1097-100.
67. Pereira BJG, Wright TL, Schmid CH, Levey AS, for the New England Organ Bank Hepatitis C Study Group. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 1995;60:799-805.
68. Stempel CA, Lake J, Kuo G, Vincenti F. Hepatitis C - its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993;55: 273-6.
69. Huang C-C, Liaw Y-F, Lai M-K, Chu S-H, Chuang C-K, Huang J-Y. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 1992;53:763-5.
70. Ponz E, Campistol JM, Barrera JM, Gil C, Pinto J, Andreu J, Bruguera M. Hepatitis C virus antibodies in patients on hemodialysis and after transplantation. Transplant Proc 1991;23:1371-2.
71. Roth D, Zucker K, Cirocco R, DeMattos A, Burke GW, Nery J, Esquenazi V, Babischkin S, Miller J. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1994;45:238-44.
72. Roth D. Hepatitis C virus: The nephrologist's view. Am J Kidney Dis 1995;25:3-16.
73. Ynares C, Johnson HK, Kerlin T, Crowe D, MacDonell R, Richie R. Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival-a 5- and 10-year follow-up. Transplant Proc 1993;25:1466-8.
74. Fritsche C, Brandes JC, Delaney SR, Gallagher-Lepak S, Manitove JE, Rich L, Scannell C, Swanson P, Lee HH. Hepatitis C is a poor prognostic indicator in black kidney transplant recipients. Transplantation 1993;55:1283-7.
75. Rao KV, Anderson RW, Kasiske BL, Dahl DC. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 1993;94:241-50.
76. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, Hollinger FB, Gitnick G, Knodell RG, Perrillo RP, Stevens CE, Hollingsworth CG, The National Heart L, and Blood Institute Study Group. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992;327:1906-11.
77. Ruiz P, Gomez F, Schreiber A. Impaired function of macrophage Fc gamma receptors in end-stage renal disease. New Engl J Med 1990;322:717-22.
78. Goldblum SE, Recd WP. Host defenses and immunologic alterations associated with chronic hemodialysis (Review). Ann Intern Med 1980;93:597-613.
79. Parfrey PS, Forbes RDC, Hutchinson TA, Kenick S, Farge D, Dauphinee WD, Seely JF, Guttmann RD. The impact of renal transplantation on the course of hepatitis B liver disease. Transplantation 1985;39:610-5.
80. Harnett JD, Zeldis JB, Parfrey PS, Kennedy M, Sircar R, Steinman TI, Guttmann RD. Hepatitis B in dialysis and transplant patients. Transplantation 1987;44:369-76.
81. Rubin RH, Tolkoff-Rubin NE. Infection: The new problems. Transplant Proc 1989;21:1440-5.
82. Pereira BJG, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991;325:454-60.
83. Roth D, Fernandez J, DeMattos A, Burke G, Nery JR, Babischkin S, Esquenazi V, Miller J. The impact of hepatitis C virus (HCV) on the potential renal allograft recipient (Abstract). J Am Soc Nephrol 1992;3:878.
84. Bjoro K, Froland S, Yun Z, Samdal H, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immunoglobulin. N Engl J Med 1994;331:1607-11.
85. Pereira BJG, Natov SN, Bouthot BA, Murthy BVR, Ruthazer R, Schmid CH, Levey AS, and The New England Organ Bank Hepatitis C Study Group. Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease. Kidney Int 1998;53:1374-81.
86. Port F, Wolfe R, Mauger E, Berling D, Jiang K. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 1993;270:1339-43.
87. Knoll GA, Tankersley MR, Lee JY, Julian BA, Curis JJ. The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients. Am J Kidney Dis 1997;29:608-14.